Table 1.
Characteristics | CDI patients n = 66 | Non CDI Patients n = 508 | |
---|---|---|---|
Toxigenic C.difficile Isolates, (A+B+, A-B+), | Negative C.difficile strains n = 410 | Non-toxigenic C.difficile strains (A-B-), n = 98 | |
Count (%) | Count (%) | Count (%) | |
Sex | |||
Male | 31 (47.0) | 208 (53.2) | 49(52.1) |
Antibiotic treatment within 8 weeks | |||
Aminoglycosides | 20 (30.3) | 70 (17.6) | 20 (21.1) |
Vancomycin | 0 | 3 (0.7) | 0 |
Cephalosporin | 24 (36.4) | 178 (44.8) | 42 (44.2) |
Metronidazole | 11 16.7) | 6 (1.5) | 2 (2.1) |
Clindamycin | 31 (46.9) | 137 (34.5) | 31 (32.6) |
Gastroenteritis diseases | 35 (53.0) | 44 (11.1) | 14 (14.9) |
Residence in nursing home | 14 (21.2) | 7 (1.8) | 3 (3.2) |
Chronic renal insufficiency | 26 (39.4) | 47 (11.9) | 16 (17.0) |
Previous Surgery | 50 (75.8) | 137 (34.7) | 51 (53.7) |
Chemotherapy | 16 (24.2) | 25(6.0) | 13 (13.3) |
Ward | |||
Internala | 28 (42.4) | 293 (73.4) | 61(64.2) |
ICU | 38 (57.6) | 106 (26.6) | 34 (35.8) |
aInternal ward(gasteroenterology, Infectious diseasese, Diabetes,…)